DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Tube Investments of India Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 58 min ago·8 Oct 2026, 9:21 am

Tube Investments of India

Tube Investments of India (TIINDIA) has informed the stock exchanges about receiving a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance is a standard requirement for entities involved in securities transactions and does not indicate any specific corporate action or news event.

For investors, this update is largely procedural and serves to confirm the company's adherence to regulatory norms. It does not signal any material change in the company's business operations or financial outlook. The information is meant to ensure transparency and is not expected to impact the stock's short-term price movement.

Investors should continue to focus on the company's operational performance and market trends. This filing is a routine regulatory disclosure and does not require any immediate reaction from the investor base.